Skip to main content


Executive Director, International Vaccine Access Center

Contact Info

615 N. Wolfe Street, Room E6547

Research Interests

Infectious diseases; vaccine-preventable diseases; infectious disease epidemiology; child health; pediatrics; measles; HIV; malaria; complex emergencies; Africa; India
Experiences & Accomplishments
Columbia University
Columbia University
William Moss is a Professor in the Departments of Epidemiology, International Health and Molecular Microbiology and Immunology at the Johns Hopkins Bloomberg School of Public Health, Executive Director of the International Vaccine Access Center, and a Deputy Director at the Johns Hopkins Malaria Research Institute. He is a pediatrician with subspecialty training in infectious diseases, and has worked in Ethiopia, Kenya, South Africa, Zambia, Zimbabwe and India among other countries. His broad research interests are the epidemiology and control of childhood infections in resource-poor countries. The specific focus of his current research is in understanding the impact of the HIV epidemic on measles control and eradication, the epidemiology and control of malaria in southern Africa, the use of serosurveillance to guide immunization programs, and the care and treatment of HIV-infected children in rural Zambia.
Honors & Awards
1999-2001 Wyeth-Lederle Vaccines and Pediatrics Young Investigator Award in Vaccine Development presented by the Infectious Disease Society of America 
2001 The Gustave J. Martin Innovative Research Fund Fellow, Johns Hopkins University Bloomberg School of Public Health Faculty Innovation Fund
2007-2008 Advising, Mentoring and Teaching Recognition Award. Student Assembly Honors & Awards Committee. Bloomberg School of Public Health
Select Publications
Publications of greatest interest
  • Click for list of all Moss WJ citations in PubMed
  • Bobat R, Coovadia H, Stephen C, Naidoo KL, McKerrow N, Black RE, Moss WJ.  Safety and efficacy of zinc supplementation in HIV-infected children: randomized, double-blind, placebo-controlled trial. Lancet 2005;366:1862-7.
  • Moss WJ, Scott S, Mugala N, Ndhlovu Z, Beeler J, Audet S, Ngala M, Mwangala S, Nkonga-Mwangilwa C, Ryon JR, Monze M, Kasolo F, Quinn TC, Cousens S, Griffin DE, Cutts FT.  Immunogenicity of standard-titre measles vaccine in HIV-1-infected and uninfected Zambian children: an observational study. J Infect Dis 2007;196;347-55.
  • Lowther SA, Curriero FC, Kalish B, Shields TM, Monze M, Moss WJ.  Population immunity to measles virus and the effect of HIV-1 infection after a mass measles vaccination campaign in Lusaka, Zambia: a cross-sectional survey. Lancet 2009;373:1025-32.
  • Rainwater-Lovett K, Nkamba H, Mubiana-Mbewe M, Bolton-Moore C, Moss WJ. Changes in measles serostatus among HIV-infected Zambian children initiating antiretroviral therapy before and after the 2010 measles outbreak: a prospective cohort study. J Infect Dis 2013; 208:1747-55. PMCID: PMC3814842
Immune Reconstitution Of HIV-1 Infected Zambian Children Initiating Antiretroviral Therapy
Prevention of Haemophilus Influenzae, Type b in India - A Probe Study to Evaluate the Burden of Disease
Safety and efficacy of zinc supplementation in HIV-1 infected children
Impact of the HIV epidemic on measles and measles control
Factors influencing the care and treatment of HIV-1-infected children in rural Zambia.
Malaria transmission dynamics in southern Zambia
IPV Advocacy Efforts to Support Endgame Strategies
DFA Immunity Assessment Device
PHE Pediatric AntiRetroviral Therapy (PART) Study
Health Research Challenge for Impact: HIV
International Centers for Excellence in Malaria Research (ICEMR)
Novel Screening of HIV Exposed Babies (NSEBA)
Severe malaria outcomes
Southern and Central Africa International Centers of Excellence for Malaria Research
Strengthening Immunization Systems through Serosurveillance
Malaria Transmission and the Impact of Control Efforts in Southern Africa
Vaccine Delivery IVAC Umbrella Grant (Multi-Project Grant)